Abstract:Objective: Our aim was to determine whether the clinical features of 21-hydroxylase-deficient nonclassic adrenal hyperplasia are correlated with either age at symptom onset or age at presentation, or both, and with the degree of adrenocortical abnormality. Study design: In a multicenter cohort design 220 women with nonclassic adrenal hyperplasia, with a basal or adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone level >30.3 nmol/L, were studied, either prospectively (n = 39) or retrospectively (n = 181). Patients were stratified by age of presentation into 5 groups: (1) <10 years (n = 25), (2) 10 to 19 years (n = 64), (3) 20 to 29 years (n = 83), (4) 30 to 39 years (n = 30), and (5) 40 to 49 years (n = 16). Two patients >50 years old were excluded from the analysis because of age. Results: Ninety-two percent of patients <10 years old had premature pubarche at presentation, whereas clitoromegaly and acne were each present in only 20% of these younger subjects. With only patients > or =10 years old considered, presenting clinical features included hirsutism (59%), oligomenorrhea (54%), acne (33%), infertility (13%), clitoromegaly (10%), alopecia (8%), primary amenorrhea (4%), and premature pubarche (4%). Among the patients >/=10 years old, the prevalence but not the degree of hirsutism increased significantly with age. Basal levels of 17-hydroxyprogesterone in adolescents were significantly higher than the levels found either in children (<10 years old) or women 40 to 49 years old (P <.01 and P <.03, respectively), although no difference was noted in the stimulated 17-hydroxyprogesterone levels between age groups. The adrenocorticotropic hormone-stimulated levels but not the basal levels of 17-hydroxyprogesterone were significantly higher in patients with clitoromegaly than in women without clitoromegaly. Alternatively, there were no differences in either basal or stimulated 17-hydroxyprogesterone levels between patients with and those without hirsutism, acne, or alopecia. Conclusion: In children <10 years old the most common presenting complaint was premature pubarche, whereas hirsutism and oligomenorrhea were more common in older patients. The prevalence of hirsutism increased with age, suggesting the progressive nature of nonclassic adrenal hyperplasia. Furthermore, the adrenocorticotropic hormone-stimulated levels of 17-hydroxyprogesterone were higher in patients with clitoromegaly, which suggests that the degree of adrenocortical dysfunction in nonclassic adrenal hyperplasia determines, at least in part, the clinical presentation.

Nonclassic Adrenal Hyperplasia (NCAH) Due to 21-Hydroxylase Deficiency: A Cohort of 78 Patients.

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

A3309 Clinical and Genetic Analysis of a Pedigree with Congenital Adrenal Hyperplasia (17Α-Hydroxylase /17,20-Lyase Deficiency) Literature

Prevalence of CYP17A1 Gene Mutations in 17Α-Hydroxylase Deficiency in the Chinese Han Population

21-Hydroxylase Deficiency-Induced Congenital Adrenal Hyperplasia in 230 Chinese Patients: Genotype–phenotype Correlation and Identification of Nine Novel Mutations

Molecular Characterization of 25 Chinese Pedigrees with 21-Hydroxylase Deficiency

Genotype-phenotype Correlation in Patients with 21-Hydroxylase Deficiency

Rare nonclassic type of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and genotype-phenotypic correlation

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults

Genetic and Phenotypic Spectrum of Non-21-hydroxylase-deficiency Primary Adrenal Insufficiency in Childhood: Data from 111 Chinese Patients.

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study

Genotype–phenotype Correlation Study and Mutational and Hormonal Analysis in a Chinese Cohort with 21‐hydroxylase Deficiency

Congenital adrenal hyperplasia disorder due to 17 α-hydroxylase deficiency: a case report

Identification of a Novel Compound Heterozygous Mutation of the CYP21A2 Gene Causing 21-Hydroxylase Deficiency in a Chinese Pedigree

Identification of Novel and Rare CYP21A2 Variants in Chinese Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Genetic diagnosis and clinical analysis of 17α-hydroxylase/17, 20-lyase deficiency combined with type 2 diabetes mellitus: A case report

The spectrum of CYP21A2 gene mutations in patients with 2l-hydroxylase deficiency -induced congenital adrenal hyperplasia in a Chinese cohort

Correction To: Clinical and Molecular Characterization of 10 Chinese Children with Congenital Adrenal Hyperplasia Due to 11Beta-Hydroxylase Deficiency

A case with 21-hydroxylase deficiency combined with adrenal adenoma and testicular adrenal rest tumors

Combined 21-hydroxylase deficiency and 17α-hydroxylase/17,20-lyase deficiency :an undervirilized male

Near-Final Height in 82 Chinese Patients with Congenital Adrenal Hyperplasia Due to Classic 21-Hydroxylase Deficiency: A Single-Center Study from China